Report of the Inaugural Meeting of the TFOS i(2) = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment

Affiliations

¹ Schepens Eye Research Institute, Massachusetts Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
² Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas, and International Brain Research Organization, Alicante, Spain.
³ Complutense University of Madrid and Hospital Clinico San Carlos, Madrid, Spain.
⁴ University of Oxford, Oxford, UK.
⁵ Section of Ophthalmology, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
⁶ School of Optometry, University of Alabama, Birmingham, AL, USA.
⁷ PharmaLogic Development, Inc., San Rafael, CA, USA.
⁸ Laboratory for Experimental Ophthalmology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
⁹ School of Optometry and Vision Science, University of New South Wales, Sydney, NSW, Australia.
¹⁰ Ophthalmic Research Group, Life and Health Sciences, Aston University, Birmingham, UK.
¹¹ Schepens Eye Research Institute, Massachusetts Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. Electronic address: david.sullivan@schepens.harvard.edu.

PMID: 26774910
DOI: 10.1016/j.jtos.2015.11.003

Report of the Inaugural Meeting of the TFOS i(2) = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment

Wendy Chao et al. Ocul Surf. 2016 Apr.

. 2016 Apr;14(2):264-316.

doi: 10.1016/j.jtos.2015.11.003. Epub 2016 Jan 14.

Authors

Affiliations

¹ Schepens Eye Research Institute, Massachusetts Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
² Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas, and International Brain Research Organization, Alicante, Spain.
³ Complutense University of Madrid and Hospital Clinico San Carlos, Madrid, Spain.
⁴ University of Oxford, Oxford, UK.
⁵ Section of Ophthalmology, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
⁶ School of Optometry, University of Alabama, Birmingham, AL, USA.
⁷ PharmaLogic Development, Inc., San Rafael, CA, USA.
⁸ Laboratory for Experimental Ophthalmology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
⁹ School of Optometry and Vision Science, University of New South Wales, Sydney, NSW, Australia.
¹⁰ Ophthalmic Research Group, Life and Health Sciences, Aston University, Birmingham, UK.
¹¹ Schepens Eye Research Institute, Massachusetts Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. Electronic address: david.sullivan@schepens.harvard.edu.

PMID: 26774910
DOI: 10.1016/j.jtos.2015.11.003

Abstract

On March 21, 2015, a meeting was held in London, United Kingdom, to address the progress in targeting the unmet need for dry eye disease (DED) treatment. The meeting, which launched the i(2) = initiating innovation series, was sponsored by the Tear Film & Ocular Surface Society (TFOS; www.TearFilm.org) and supported by Dompé. The TFOS i(2) meeting was designed to review advances in the understanding of DED since publication of the 2007 TFOS International Dry Eye WorkShop (DEWS) report, and to help launch the highly anticipated sequel, DEWS II. The meeting was structured to discuss the scope of the DED problem, to review the clinical challenges of DED, and to consider the treatment challenges of DED. This article provides a synopsis of the presentations of this TFOS i(2) meeting.

Keywords: Clinical trials; Dry Eye WorkShop II (DEWS II); Tear Film & Ocular Surface Society; drug development; dry eye disease (DED); i(2) = initiating innovation series.

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Report of the Inaugural Meeting of the TFOS i(2) = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment

Affiliations

Report of the Inaugural Meeting of the TFOS i(2) = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment

Authors

Affiliations

Abstract

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources